Imaging Cellular Proliferation During Chemo-Radiotherapy: A Pilot Study of Serial 18F-FLT Positron Emission Tomography/Computed Tomography Imaging for Non-Small-Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 4, 2009, Pages 1098-1104

  Everitt, Sarah ^a,b   Hicks, Rodney J ^a   Ball, David ^a   Kron, Tomas ^a   Schneider Kolsky, Michal ^b   Walter, Tania ^a   Binns, David ^a   Mac Manus, Michael ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

18F 3 deoxy 3 fluoro L thymidine; 18F FLT; Cellular proliferation; Non small cell lung cancer; Positron emission tomography; Radiotherapy

Indexed keywords

18F-FLT; BIOLOGIC RESPONSE; BONE MARROW; CELLULAR PROLIFERATION; CELLULAR PROLIFERATIONS; COMPUTED TOMOGRAPHY SCAN; NON SMALL CELL LUNG CANCER; NORMAL TISSUE; PILOT STUDIES; POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHIES; PROOF OF CONCEPT; TIME POINTS; TUMOR UPTAKE;

BIOLOGICAL ORGANS; CELL PROLIFERATION; COMPUTERIZED TOMOGRAPHY; ELECTRONS; POSITRONS; RADIOTHERAPY; TUMORS;

POSITRON EMISSION TOMOGRAPHY;

3' FLUOROTHYMIDINE F 18; CARBOPLATIN; FLUORODEOXYGLUCOSE F 18; PACLITAXEL; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; 3' FLUOROTHYMIDINE; DIAGNOSTIC AGENT; FLUORINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BONE MARROW; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MALE; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; TIME; TREATMENT RESPONSE; TUMOR VOLUME; COMPARATIVE STUDY; EVALUATION; LUNG TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SCINTISCANNING;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; COMBINED MODALITY THERAPY; DIDEOXYNUCLEOSIDES; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70449725575     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.12.039     Document Type: Article

References (33)

1. Hall E.J., and Garcia A.J. Radiobiology for the radiologist. Sixth ed. (2006), Lippincott Wilkins & Williams, Philadelphia p. 36
2. Aerts H.J., Bosmans G., van Baardwijk A.A., et al. Stability of (18)F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: A prospective study. Int J Radiat Oncol Biol Phys 71 (2008) 1402-1407
3. Kong F.M., Frey K.A., Quint L.E., et al. A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer. J Clin Oncol 25 (2007) 3116-3123
4. van Baardwijk A., Bosmans G., Dekker A., et al. Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients. Radiother Oncol 82 (2007) 145-152
5. Gillham C., Zips D., Pönisch F., et al. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?. Radiother Oncol 88 (2008) 335-341
6. Higashi K., Clavo A.C., and Wahl R.L. In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J Nucl Med 34 (1993) 773-779
7. Strauss L.G. Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients. Eur J Nucl Med 23 (1996) 1409-1415
8. Halter G., Buck A.K., Schirrmeister H., et al. [18F] 3-deoxy-3′-fluorothymidine positron emission tomography: Alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-d-glucose positron emission tomography in the workup of suspicious central focal lesions?. J Thorac Cardiovasc Surg 127 (2004) 1093-1099
9. Rasey J.S., Grierson J.R., Wiens L.W., et al. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. J Nucl Med 43 (2002) 1210-1217
10. Shields A.F. Positron emission tomography measurement of tumor metabolism and growth: Its expanding role in oncology. Mol Imaging Biol 8 (2006) 141-150
11. Yap C.S., Czernin J., Fishbein M.C., et al. Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography. Chest 129 (2006) 393-401
12. Shields A.F., Grierson J.R., Dohmen B.M., et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 4 (1998) 1334-1336
13. Been L.B., Suurmeijer A.J., Cobben D.C., et al. [18F]FLT-PET in oncology: Current status and opportunities. Eur J Nucl Med Mol Imaging 31 (2004) 1659-1672
14. Sherley J.L., and Kelly T.J. Regulation of human thymidine kinase during the cell cycle. J Biol Chem 263 (1988) 8350-8358
15. Buck A.K., Halter G., Schirrmeister H., et al. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. J Nucl Med 44 (2003) 1426-1431
16. Yamamoto Y., Nishiyama Y., Ishikawa S., et al. Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer. Eur J Nucl Med Mol Imaging 34 (2007) 1610-1616
17. Muzi M., Vesselle H., Grierson J.R., et al. Kinetic analysis of 3′-deoxy-3′-fluorothymidine PET studies: Validation studies in patients with lung cancer. J Nucl Med 46 (2005) 274-282
18. van Westreenen H.L., Cobben D.C., Jager P.L., et al. Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer. J Nucl Med 46 (2005) 400-404
19. Roels S., Slagmolen P., Nuyts J., et al. Biological image-guided radiotherapy in rectal cancer: Is there a role for FMISO or FLT, next to FDG?. Acta Oncol 47 (2008) 1237-1248
20. Wieder H.A., Geinitz H., Rosenberg R., et al. PET imaging with [18F]3′-deoxy-3′-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer. Eur J Nucl Med Mol Imaging 34 (2007) 878-883
21. Pan M.H., Huang S.C., Liao Y.P., et al. FLT-PET imaging of radiation responses in murine tumors. Mol Imaging Biol 10 (2008) 325-341
22. Perumal M., Pillai R.G., Barthel H., et al. Redistribution of nucleoside transporters to the cell membrane provides a novel approach for imaging thymidylate synthase inhibition by positron emission tomography. Cancer Res 66 (2006) 8558-8564
23. Fowler J.F., and Chappell R. Non-small cell lung tumors repopulate rapidly during radiation therapy. Int J Radiat Oncol Biol Phys 46 (2000) 516-517
24. Fowler J.F., Tome W.A., Fenwick J.D., et al. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 60 (2004) 1241-1256
25. Mehta M., Scrimger R., Mackie R., et al. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 49 (2001) 23-33
26. Trott K.R., and Kummermehr J. Rapid repopulation in radiotherapy: A debate on mechanism. Accelerated repopulation in tumours and normal tissues. Radiother Oncol 22 (1991) 159-160
27. Nestle U., Kremp S., and Grosu A.-L. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 81 (2006) 209-225
28. Dwamena B.A., Sonnad S.S., Angobaldo J.O., et al. Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s-meta-analytic comparison of PET and CT. Radiology 213 (1999) 530-536
29. Mac Manus M.P., Hicks R.J., Matthews J.P., et al. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. J Clin Oncol 21 (2003) 1285-1292
30. Bading J.R., and Shields A.F. Imaging of cell proliferation: Status and prospects. J Nucl Med 49 Suppl 2 (2008) 64S-S80S
31. Cobben D.C., Elsinga P.H., Hoekstra H.J., et al. Is 18F-3′-fluoro-3′-deoxy-l-thymidine useful for the staging and restaging of non-small cell lung cancer?. J Nucl Med 45 (2004) 1677-1682
32. Hicks R.J. The role of PET in monitoring therapy. Cancer Imaging 5 (2005) 51-57
33. Withers H.R., Taylor J.M., and Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27 (1988) 131-146